Stock Research: Ipsen

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Ipsen

ENXTPA:IPN FR0010259150
81
  • Value
    86
  • Growth
    45
  • Safety
    Safety
    88
  • Combined
    94
  • Sentiment
    43
  • 360° View
    360° View
    81
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Ipsen SA is a biopharmaceutical group specializing in specialty care. The company operates in the specialty care and consumer healthcare industries, with a focus on oncology, neurosciences, and rare diseases. It operates globally, with research and development centers in France, the United Kingdom, and the United States. In the last fiscal year, the company had a market cap of $10,169 million, profits of $3,060 million, and revenue of $3,701 million, with 5358 employees.

more
Index
CAC All
SBF 120
Employee Focus EU
Moonshot Tech
Renewables Users
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 8-Jan-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
86 86 67 82
Growth
45 47 21 75
Safety
Safety
88 69 54 62
Sentiment
43 27 48 80
360° View
360° View
81 74 45 98
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
16 11 24 19
Opinions Change
50 18 43 92
Pro Holdings
n/a 69 61 82
Market Pulse
71 49 71 41
Sentiment
43 27 48 80
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
86 86 67 82
Growth
45 47 21 75
Safety Safety
88 69 54 62
Combined
94 81 38 94
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
56 53 52 79
Price vs. Earnings (P/E)
83 89 81 92
Price vs. Book (P/B)
68 67 57 69
Dividend Yield
47 52 49 53
Value
86 86 67 82
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
29 47 46 20
Profit Growth
63 23 25 63
Capital Growth
76 80 7 88
Stock Returns
43 55 62 70
Growth
45 47 21 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
84 78 68 41
Refinancing
59 25 15 48
Liquidity
81 76 75 65
Safety Safety
88 69 54 62

Similar Stocks

Discover high‑ranked alternatives to Ipsen and broaden your portfolio horizons.

Synergie

ENXTPA:SDG
Country: France
Industry: HR- & Employment Services
Size: Medium
Full Stock Analysis

Rubis

ENXTPA:RUI
Country: France
Industry: Gas Utilities
Size: Medium
Full Stock Analysis

Krka

LJSE:KRKG
Country: Slovenia
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Ipsos

ENXTPA:IPS
Country: France
Industry: Advertising
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This stock is a good value with safe financing, but has low growth and negative sentiment. It is a good option for a cautious value investor looking for stability but who can tolerate low momentum and skeptical professional opinion.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: